Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement

Bainan Liua, Weihong Tanb, Adel Barsouma, Xiaogang Guc, Kong Chenc, Weitao Huangc, Alistair Ramsayc, Jay Kollsc, Paul SchwarzenbergeraCorresponding Author Informationemail address

Received 6 May 2010; received in revised form 31 May 2010; accepted 10 June 2010. published online 21 June 2010.
Uncorrected Proof

Objective

Interleukin (IL)-17, which now defines the Th17 immune response, is a critical cytokine expressed and required for stress granulopoiesis during microbial invasion. Dendritic cells (DC) can instigate this response by inducing IL-17 expression in CD4+ T cells. Besides IL-17, microbial invasion also stimulates production of the DC growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF). The objective was the in vitro and in vivo investigation of IL-17 on DC proliferation and function in mice.

Materials and Methods

Murine IL-17 (mIL-7) or murine GM-CSF (mGM-CSF), or both, was expressed in C57BL6 mice using adenoviral technology to assess hematopoietic and DC changes. The E-22 tymoma tumor cell line using a previously described vaccinia virus ovalbumin/LacZ murine tumor model was employed to study effects on tumor rejection.

Results

The combination of mIL-17 and mGM-CSF increased peripheral neutrophila by 28-fold and splenic colonies by 11- and 14-fold over each individual factor in mice, respectively. The effect of mIL-17 by itself on murine DCs in vitro and in vivo was minimal; however, the combination greatly enhanced the stimulating effects of mGM-CSF, increasing the total numbers of CD14b/c+ spleen DC by fourfold, as well as their function measured by enhanced endocytosis. Mixed lymphocyte reactions using mIL-17/mGM-CSF cultured DCs stimulator cells enhanced lymphocyte responses by twofold over mGM-CSF alone. Vaccination against LacZ in the C57BL6 E22 syngenic thymoma tumor model effectively delayed tumor growth in animals pretreated with the mIL-17/mGM-CSF combination prior to vaccination.

Conclusions

mIL-17 effectively synergizes with mGM-CSF in stimulating granulopoiesis and DC expansion, as well as in functional enhancement of DCs.

a Quantumimmunologics, Tampa, Fla., USA

b Department of Gynecology, People's Hospital of Guangxi, People's Republic of China

c Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, La., USA

Corresponding Author InformationOffprint requests to: Paul Schwarzenberger, M.D., Quantumimmunologics, Cancer Immunology, 1881 W. Kennedy Boulevard, Tampa, FL 33623-0727

PII: S0301-472X(10)00239-0

doi:10.1016/j.exphem.2010.06.004